bio1

AKESOgen receives a prestigious Deal of the Year Award at the Annual Georgia Bio Awards Night

IMG_2374

AKESOgen receives a prestigious Deal of the Year Award at the Annual Georgia Bio Awards Night

Atlanta, USA – 22nd January 2015— AKESOgen was recognized by its peers from the Biotechnology industry at a gala event at the Fox Theatre in Atlanta for its public/ private partnership alliance and outstanding work with the US Department of Veteran’s Affairs.

“We are delighted to be honored by our peers and are particularly proud to be chosen amongst a stellar group of organizations that are true world leaders in the global market and are great examples of the thriving biotechnology community in the state of Georgia” said Bob Boisjoli, CEO of AKESOgen.

The US Department of Veterans Affairs Million Veteran Program is the largest genetic initiative ever undertaken in the US and its visionary genomics and genetics approach will provide new insights about how genes affect health. The goal is to improve healthcare for veterans by understanding the genetic basis of many common conditions. The data will ultimately be beneficial to the healthcare of all veterans and of the wider community.

“We are extremely excited to support the VA for this unique endeavor as we provide genetic data of the highest quality to the VA. AKESOgen is delivering over 800,000 genetic datapoints to the VA for each of the patients it provides analysis making up many terabytes of information each year” commented Mark Bouzyk, CSO of AKESOgen.

About AKESOgen, Inc.
AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in Atlanta USA, the company’s main focus is oncology and personalized medicine. AKESOgen’s services include providing high-throughput, sequencing, genotyping, biomarker profiling, cytogenetic arrays and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. For more information, visit www.akesogen.com.

Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

Media Contacts:

Mark Bouzyk, PhD, Chief Scientific Officer. AKESOgen, Inc. +1 770-542-0890 ext 101 (office), or mbouzyk@akesogen.com

Maria Thacker, VP of Operations. Georgia Bio. +1 404-920-2042 (office), or maria.thacker@gabio.org

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail